Search

Too many women accept uterine fibroid symptoms such as heavy periods, abdominal bulkiness, and pelvic pain as normal. But they don’t have to! Learn about treatment options from medication to surgery in this week’s MedBlog. Read more.

Sickle cell disease is a genetic condition that can cause significant pregnancy issues. Find out what women need to know to safely manage symptoms and reduce risks for themselves and their babies. Learn more.

We know that smartphone use before bed disrupts our sleeping habits. But it’s impractical today to say mobile devices should be banned from the bedroom. In this MedBlog, we discuss how technology can promote better sleep – rather than hinder it.

Millions of women experience fecal incontinence – debilitating bowel leakage – with limited treatment options. Until now. PTNS, an innovative nerve therapy, might be a game-changer, and it’s only available through this clinical trial. Learn more.

Ashley Byrnes had an easy pregnancy and delivery. But 8 days after giving birth, she nearly died from postpartum hemorrhage – excessive bleeding after childbirth. Today, she shares her story to raise awareness and education for patients and providers alike. Learn more.

An integrative approach to health includes not only good nutrition, adequate exercise and sleep, but also engaging in positive relationships and stress management. The last six decades have brought forth extensive evidence that meditation and the mind-body connection can have tangible effects on your health.

Frozen shoulder is a mysterious, miserable condition we face as we age. When sleepless, painful nights began to affect Tim Rogers’ work as editor of D Magazine, he sought help from UT Southwestern and potentially cut his recovery time by 75%. Learn more.

Invisible acoustic neuroma surgery is an advanced technique for tumor removal that results in no visible scarring. UT Southwestern is one of just two centers in the U.S. to offer this procedure.

Is it safe to drink 25 cups of coffee a day like a 2019 study suggests? UT Southwestern says probably not. Find out where the confusion comes from and what the experts say in this week’s MedBlog. Learn more.

For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, UT Southwestern discusses these therapies and what they mean for North Texas patients.